- Companies
- Shanghai MicroPort
Shanghai MicroPort Valuation Multiples
Shanghai MicroPort is valued at $1.5B as of September 2026, a 5.6x revenue multiple. In the last FY Shanghai MicroPort reported revenue of $201M and EBITDA of $108M.
Shanghai MicroPort Overview
About Shanghai MicroPort
Shanghai MicroPort Endovascular MedTech (Group) Co Ltd is engaged in the research and development (R&D), manufacturing, sales and services of aortic, peripheral vascular and tumor intervention devices. Its product portfolio includes thoracic and abdominal aortic stent grafts, peripheral vascular stents, drug-coated balloon dilatation catheters, balloon dilatation catheters, vena cava filters, snare retrieval kits, thrombectomy devices, and tumor embolization microspheres. The company markets its products in China and international markets, including Europe, Latin America, Asia, and Africa.
Founded
2012
HQ
Employees
N/A
Website
Financials (LTM)
EV
$1.2B
Valuation Multiples
Start free trialShanghai MicroPort Financials
Shanghai MicroPort reported last 12-month revenue of $219M and EBITDA of $116M.
In the same LTM period, Shanghai MicroPort generated $155M in gross profit, $116M in EBITDA, and $89M in net income.
Revenue (LTM)
Shanghai MicroPort P&L
In the most recent fiscal year, Shanghai MicroPort reported revenue of $201M and EBITDA of $108M.
Shanghai MicroPort is profitable as of last fiscal year, with gross margin of 71%, EBITDA margin of 54%, and net margin of 42%.
Financial data powered by Morningstar, Inc.
Shanghai MicroPort Stock Performance
Shanghai MicroPort has current market cap of $1.5B, and enterprise value of $1.2B.
Market Cap Evolution
Shanghai MicroPort's stock price is $12.55.
Shanghai MicroPort share price decreased by 22.6% in the last year.
Shanghai MicroPort has an EPS (earnings per share) of $0.68.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $1.5B | -0.2% | - | -3.8% | -22.6% | $0.68 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShanghai MicroPort Valuation Multiples
Shanghai MicroPort trades at 5.6x EV/Revenue multiple, and 10.6x EV/EBITDA.
EV / Revenue (LTM)
Shanghai MicroPort Financial Valuation Multiples
As of September 18, 2026, Shanghai MicroPort has market cap of $1.5B and EV of $1.2B.
Shanghai MicroPort has a P/E ratio of 17.3x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shanghai MicroPort Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Shanghai MicroPort Margins & Growth Rates
Shanghai MicroPort grew revenue by 13% and EBITDA by 10% in the last fiscal year.
In the most recent fiscal year, Shanghai MicroPort reported gross margin of 71%, EBITDA margin of 54%, and net margin of 42%.
Shanghai MicroPort Margins
Shanghai MicroPort Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Shanghai MicroPort Operational KPIs
Shanghai MicroPort's Rule of 40 is 65% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shanghai MicroPort's Rule of X is 85% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Shanghai MicroPort Competitors
Shanghai MicroPort competitors include Alphatec Holdings, Savaria, Beijing Balance Medical, Nakanishi, 4DMedical, El.En. Group, BoneSupport, Nihon Kohden, Haier Biomedical and Nolato.
Most Shanghai MicroPort public comparables operate across Medical Devices, DeepTech and HealthTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $764M | ($15M) | 2.7x | 2.5x | (140.5x) | 16.6x | |||
| $655M | $113M | 2.5x | 2.3x | 14.3x | 11.2x | |||
| $92M | $37M | 15.9x | - | 40.0x | - | |||
| $522M | $53M | 2.8x | 2.5x | 27.5x | 9.7x | |||
| $4M | ($18M) | 349.4x | 193.3x | (81.1x) | (25.2x) | |||
| $680M | $96M | 1.9x | 2.1x | 13.3x | 11.1x | |||
| $120M | $21M | 11.8x | 9.7x | 67.1x | 36.2x | |||
| $1.5B | $166M | 1.0x | 1.0x | 8.8x | 8.9x | |||
This data is available for Pro users. Sign up to see all Shanghai MicroPort competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shanghai MicroPort
| When was Shanghai MicroPort founded? | Shanghai MicroPort was founded in 2012. |
| Where is Shanghai MicroPort headquartered? | Shanghai MicroPort is headquartered in China. |
| Is Shanghai MicroPort publicly listed? | Yes, Shanghai MicroPort is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Shanghai MicroPort? | Shanghai MicroPort trades under 688016 ticker. |
| When did Shanghai MicroPort go public? | Shanghai MicroPort went public in 2019. |
| Who are competitors of Shanghai MicroPort? | Shanghai MicroPort main competitors include Alphatec Holdings, Savaria, Beijing Balance Medical, Nakanishi, 4DMedical, El.En. Group, BoneSupport, Nihon Kohden, Haier Biomedical, Nolato. |
| What is the current market cap of Shanghai MicroPort? | Shanghai MicroPort's current market cap is $1.5B. |
| What is the current revenue of Shanghai MicroPort? | Shanghai MicroPort's last 12 months revenue is $219M. |
| What is the current revenue growth of Shanghai MicroPort? | Shanghai MicroPort revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Shanghai MicroPort? | Current revenue multiple of Shanghai MicroPort is 5.6x. |
| What is the current EBITDA of Shanghai MicroPort? | Shanghai MicroPort's last 12 months EBITDA is $116M. |
| What is Shanghai MicroPort's EBITDA margin? | Shanghai MicroPort's last 12 months EBITDA margin is 53%. |
| What is the current EV/EBITDA multiple of Shanghai MicroPort? | Current EBITDA multiple of Shanghai MicroPort is 10.6x. |
| What is the current FCF of Shanghai MicroPort? | Shanghai MicroPort's last 12 months FCF is $37M. |
| What is Shanghai MicroPort's FCF margin? | Shanghai MicroPort's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Shanghai MicroPort? | Current FCF multiple of Shanghai MicroPort is 33.3x. |
| How many companies Shanghai MicroPort has acquired to date? | Shanghai MicroPort hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Shanghai MicroPort has invested to date? | Shanghai MicroPort hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Shanghai MicroPort
Lists including Shanghai MicroPort
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




